Navigating FDA Compliance With a Supplement Regulatory Consultant

Dietary supplement development operates within a regulatory framework that differs from both conventional food and pharmaceutical products.

Brands need to consider ingredient status, labeling, product claims, manufacturing practices, documentation and quality systems throughout development—not simply when the product is ready to launch.

A supplement regulatory consultant can help identify which requirements apply to a specific product and integrate those considerations into formulation, manufacturing and commercialization.

That matters because FDA generally does not approve dietary supplements before they are marketed. Companies are responsible for making sure the products they manufacture or distribute comply with applicable federal requirements.

This guide explains the major areas of FDA compliance for supplements, including DSHEA, New Dietary Ingredient notifications, structure/function claims, labeling, cGMP and quality systems.

If you're developing a supplement and aren't sure where regulatory considerations fit into the product development process, KitChem can help connect technical decisions with the broader commercialization path.

What Does a Supplement Regulatory Consultant Do?

A supplement regulatory consultant helps companies understand and apply regulatory requirements relevant to dietary supplements.

Depending on the product and organization, that may include:

• Ingredient regulatory review
• Product classification
• New Dietary Ingredient considerations
• Label review
• Claim evaluation
• cGMP considerations
• Quality documentation
• Regulatory submissions
• Risk assessment
• Commercialization readiness

The goal is to identify potential issues early enough that regulatory requirements can inform development rather than forcing major changes immediately before launch.

What Is DSHEA?

The Dietary Supplement Health and Education Act of 1994, commonly known as DSHEA, created key provisions of the modern federal framework governing dietary supplements.

Among other things, the framework distinguishes dietary supplements from conventional foods and drugs and establishes requirements involving ingredients, claims and manufacturer responsibilities.

Supplements Are Not Pre-Approved Like Drugs

Dietary supplements generally do not go through FDA premarket approval in the way new drugs do.

Instead, manufacturers and distributors are responsible for ensuring their products comply with applicable law, including requirements related to safety, labeling and manufacturing.

That makes regulatory planning particularly important during product development.

When Is a New Dietary Ingredient Notification Required?

One important regulatory question is whether a product contains a New Dietary Ingredient, or NDI.

When applicable, FDA requires a premarket New Dietary Ingredient notification.

FDA states that when a dietary supplement contains an NDI subject to the notification requirement, the manufacturer or distributor must submit the notification at least 75 days before the ingredient or supplement is introduced into interstate commerce.

Ingredient History Matters

Determining whether an NDI notification may be required can involve questions about:

• The identity of the dietary ingredient
• Its history of marketing or use
• The intended conditions of use
• Whether another regulatory pathway or exception may apply

This analysis should happen before a brand builds its entire product strategy around an unfamiliar ingredient.

Why NDI Review Should Happen Early

Discovering an ingredient issue late in development can affect:

• Formulation
• Launch timing
• Supplier selection
• Product claims
• Testing
• Commercial strategy

Early review gives the product team more options.

Explore Active Ingredients →

What Are Structure/Function Claims for Supplements?

Structure/function claims describe how a nutrient or dietary ingredient may affect the normal structure or function of the human body.

FDA provides examples such as statements relating to maintaining normal body functions rather than diagnosing or treating disease.

Structure/Function Claims Cannot Be Disease Claims

A dietary supplement claim should not state or imply that the product diagnoses, treats, cures, mitigates or prevents a disease unless it is being lawfully marketed under an applicable drug framework.

The distinction can become subtle when marketing language moves from supporting a normal function to suggesting treatment of a medical condition.

Claims Need Substantiation

For structure/function claims and related claims under section 403(r)(6), firms must have substantiation that the statement is truthful and not misleading.

That means claims strategy should begin with evidence rather than marketing copy.

Do Structure/Function Claims Need to Be Submitted to FDA?

For certain structure/function, general well-being and nutrient-deficiency claims used in dietary supplement labeling, FDA requires notification no later than 30 days after the product is first marketed with the claim.

These claims also require the applicable statutory disclaimer stating that FDA has not evaluated the claim and that the product is not intended to diagnose, treat, cure or prevent disease.

Build Claims Into Development Earlier

Even though the notification itself may occur after first marketing, the supporting strategy should happen before launch.

Ask:

• What benefits will the brand communicate?
• Is there appropriate substantiation?
• Does the formula support the intended claim?
• Does the wording cross into disease territory?
• Is the required disclaimer addressed?

This connects:

Evidence → Formula → Claim → Label → Notification

What Are Dietary Supplement Labeling Requirements?

Supplement labeling includes more than product claims.

Depending on the product, label development may involve:

• Statement of identity
• Supplement Facts
• Ingredient declarations
• Net quantity
• Manufacturer, packer or distributor information
• Applicable warnings
• Required disclaimers

Supplement Facts Need to Match the Product

The panel should accurately reflect the finished product and applicable labeling requirements.

That means formula changes can affect:

• Ingredient declarations
• Amounts per serving
• Serving size
• Percent Daily Value where applicable

Review Labels After Reformulation

Any meaningful formula change should trigger a corresponding review of the label.

This helps keep the commercial presentation aligned with the actual finished product.

What Are cGMP Requirements for Dietary Supplements?

FDA's dietary supplement current good manufacturing practice, or cGMP, requirements are codified in 21 CFR Part 111.

They apply to the manufacturing, packaging, labeling and holding of dietary supplements and are designed to help ensure supplement quality and consistency.

cGMP Covers More Than Production

A compliant system can involve areas such as:

• Personnel
• Facilities
• Equipment
• Components
• Production controls
• Packaging and labeling
• Holding and distribution
• Complaints
• Records

Specifications Are Central to Quality

Specifications help define whether:

• Ingredients meet requirements
• In-process materials are acceptable
• Finished products meet established quality criteria

Without clear specifications, there is no objective standard against which quality can be evaluated.

What Testing Is Required for Supplement Quality?

Testing strategy depends on the product and applicable requirements, but quality systems may evaluate areas such as:

• Identity
• Purity
• Strength
• Composition
• Limits on potential contaminants

FDA's dietary supplement cGMP framework requires manufacturers to establish and follow systems designed to ensure the identity, purity, quality, strength and composition of supplements.

Ingredient Identity Is Especially Important

Incoming dietary ingredients need appropriate identity verification under the applicable cGMP framework.

The broader objective is to make sure the material being used in production is actually the ingredient the formula specifies.

Why Documentation Matters for FDA Compliance

Quality and regulatory work needs to be documented.

Depending on the operation, records may include:

• Ingredient specifications
• Supplier documentation
• Testing results
• Master manufacturing records
• Batch production records
• Label reviews
• Claim substantiation
• Complaint documentation
• Corrective actions

Master Manufacturing Records

The master manufacturing record defines the approved process for producing a dietary supplement.

FDA's Part 111 framework specifically ties dietary supplement quality to producing and labeling products according to the master manufacturing record.

Batch Records

Batch documentation records what actually happened during a specific production run.

Together, these records support consistency and traceability.

How Regulatory Compliance Connects to Supplement Formulation

Regulatory decisions should not exist in a separate silo from product development.

Ingredient and formulation decisions can influence:

• Product classification
• Labeling
• Claims
• Testing
• Documentation

Claims Can Influence Formula Design

If a product's positioning depends on a particular active ingredient or benefit, formulators need to understand that goal early.

Otherwise, the finished formula could technically work while failing to support the intended commercial message.

Ingredient Decisions Can Influence Launch Timing

An unfamiliar dietary ingredient may require additional regulatory evaluation or notification considerations.

That can affect the product development timeline.

Explore Product Development →

How cGMP Connects to Supplement Manufacturing

Commercial formulation cannot be separated from manufacturing controls.

A supplement needs to move from development into a process that can reproduce the product consistently.

That means considering:

• Ingredient handling
• Processing
• Batch documentation
• Specifications
• Quality testing
• Packaging and labeling

Explore Manufacturing Support →

Why Supplier Qualification Matters

Compliance begins before ingredients arrive at the manufacturing facility.

Brands and manufacturers should understand:

• Who supplies the ingredient
• What specifications apply
• What documentation is available
• Whether supply is consistent
• How quality is verified

Specialized Ingredients Can Increase Risk

Novel botanicals, specialty extracts and other active ingredients may require greater diligence around:

• Identity
• Quality
• Supplier history
• Regulatory status

Explore Sourcing Support →

How Supplement Companies Can Reduce Regulatory Risk

The strongest compliance strategy is proactive rather than reactive.

Potential risk-management systems include:

• Pre-launch regulatory review
• Claim review
• Supplier qualification
• Testing protocols
• Complaint monitoring
• Internal audits
• Corrective and preventive processes
• Regulatory monitoring

Regulatory Compliance Changes Over Time

Requirements, guidance and agency priorities can evolve.

Companies should have a system for staying current rather than treating compliance as a one-time project.

What Happens During an FDA Inspection?

FDA may inspect facilities involved in dietary supplement operations as part of its enforcement responsibilities.

Prepared organizations should be able to locate relevant:

• Procedures
• Manufacturing records
• Testing documentation
• Specifications
• Quality records

efficiently.

Build Systems for Daily Operations, Not Just Inspections

The best documentation system is one employees actually use consistently.

Creating records solely to prepare for an inspection often leads to gaps.

Regulatory systems should support normal operations and produce the required documentation as a result.

When Should You Work With a Supplement Regulatory Consultant?

Outside regulatory expertise may be valuable when:

• You're launching your first supplement
• You're introducing unfamiliar dietary ingredients
• NDI status is unclear
• The product uses complex structure/function claims
• You're entering a new product category
• Internal teams lack supplement-specific regulatory expertise
• A formula or label is changing significantly
• You're preparing quality systems for commercialization

Developing a supplement and trying to understand the regulatory path?
KitChem can help connect ingredient, formulation and commercialization decisions with the regulatory questions that need to be addressed.
Call Carolina: 213-769-7843

Expert Insight on Supplement Regulatory Strategy

Regulatory planning is most useful when it is integrated with technical development rather than added at the very end.

Expert Insight From Carolina Vazquez Mitchell

“With supplements, your ingredient strategy, claims and formulation all connect. You don't want to finish developing the product and only then discover that the way you planned to position it creates a regulatory issue. Those conversations need to happen while the formula is still being built.”

— Carolina Vazquez Mitchell, Founder, KitChem

A Supplement Regulatory Compliance Checklist

Before commercialization, evaluate:

• Product classification
• Ingredient regulatory status
• NDI considerations
• Final formula
• Supplement Facts panel
• Ingredient declarations
• Structure/function or other claims
• Claim substantiation
• Required disclaimers
• Applicable FDA notifications
• Ingredient specifications
• Manufacturing specifications
• cGMP documentation
• Final label review

Regulatory note: This is a development framework, not a substitute for product-specific regulatory or legal review. Requirements depend on the actual supplement, ingredients, claims and commercial circumstances.

Build FDA Compliance Into Supplement Product Development

Successful supplement development integrates regulatory strategy with formulation, quality and manufacturing.

The process should connect:

Concept

↓

Ingredients

↓

Formula

↓

Claims

↓

Testing

↓

Manufacturing

↓

Labeling

↓

Commercialization

A supplement regulatory consultant can help identify where regulatory questions fit into that progression, while product development experts make sure those considerations work with the actual formulation and manufacturing strategy.

KitChem supports supplement, gummy, beverage and active-ingredient development with technical considerations addressed from early formulation through commercial preparation.

‍Call Carolina: 213-769-7843